Thomas S.K. Gilbert
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
Mitochondrial Function and Pathology, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Cancer, Lipids, and Metabolism, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues(2019)197 cited
- → KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism(2018)189 cited
- → Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers(2020)103 cited
- → Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer(2019)71 cited
- → Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK(2021)51 cited
- → EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma(2018)38 cited
- → Probing the global kinome and phosphoproteome in Chlamydomonas reinhardtii via sequential enrichment and quantitative proteomics(2016)36 cited
- → Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition(2021)33 cited
- → Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals(2017)30 cited
- → Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis(2022)29 cited